Metraipolis › archive › dc_f72b6c620da9

[Nirsevimab immunization effectiveness against respiratory syncytial virus hospitalization in newborns: two season of use in Navarre, Spain] — Europe PMC PMID:40879409

Source
Europe PMC (es)
Original
https://europepmc.org/article/MED/40879409
DOI
10.23938/assn.1133
License (as archived)
solo-consultazione
Archived
2026-10-07T14:54:50.692Z
SHA-256 of the archived text
3ebd2f047a8699db2e8552d8d8abca345198ee7b9fa8d0455b1fa8ab623f9ed8
Stable URL of this page
https://metraipolis.com/documento/dc_f72b6c620da9

How to cite

[Nirsevimab immunization effectiveness against respiratory syncytial virus hospitalization in newborns: two season of use in Navarre, Spain] — Europe PMC PMID:40879409 — Europe PMC (es), https://europepmc.org/article/MED/40879409 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f72b6c620da9 (Metraipolis archive dc_f72b6c620da9, sha256 3ebd2f047a8699db2e8552d8d8abca345198ee7b9fa8d0455b1fa8ab623f9ed8)
BibTeX
@misc{dcf72b6c620da9,
  title = {[Nirsevimab immunization effectiveness against respiratory syncytial virus hospitalization in newborns: two season of use in Navarre, Spain] — Europe PMC PMID:40879409},
  howpublished = {Europe PMC (es)},
  url = {https://europepmc.org/article/MED/40879409},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f72b6c620da9; sha256 3ebd2f047a8699db2e8552d8d8abca345198ee7b9fa8d0455b1fa8ab623f9ed8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40879409. Agents can read the archived copy with the MCP tool read_document.